Skip to main content
SCM Lifescience Co., Ltd. logo

SCM Lifescience Co., Ltd. — Investor Relations & Filings

Ticker · 298060 ISIN · KR7298060005 KO Manufacturing
Open in API
Filings indexed 418 across all filing types
Latest filing 2023-09-22 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 298060

About SCM Lifescience Co., Ltd.

http://www.scmlifescience.com/en/

SCM Lifescience Co., Ltd. is a biotechnology company focused on developing high-purity, high-efficacy stem cell therapeutics for difficult-to-treat and incurable diseases. The company utilizes its proprietary source technology, the Subfractionation Culturing Method, to isolate and culture potent stem cells. Its pipeline consists of allogeneic stem cell therapies targeting immunological conditions, which are undergoing clinical trials. SCM Lifescience is also establishing mass production manufacturing processes using 3D bioreactor technology and expanding its research into induced pluripotent stem cells (iPSC) and tissue engineering. The company's business areas also include contract manufacturing (CMO), contract research, consulting, and cosmetics.

Recent filings

Filing Released Lang Actions
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically functions as a '정정신고' (Amendment Report) to a previously filed stock option grant. It details adjustments to the number of shares and exercise prices due to capital changes (bonus issues). Since this document relates to the issuance of stock options and capital structure adjustments, it falls under the category of share issuance and capital changes.
2023-09-22 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically marked as a '정정신고' (Amendment Report). It details changes to stock option quantities and exercise prices due to capital adjustments (bonus issues). Since this relates to the issuance and adjustment of equity-based compensation instruments (stock options) which affects the company's capital structure, it falls under the category of Share Issue/Capital Change.
2023-09-22 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is a correction (정정신고) of a previous filing. It details the adjustment of stock option quantities and exercise prices due to capital changes (유무상증자). This type of filing, which relates to the issuance or modification of stock-based compensation instruments, falls under the category of share issues or capital changes.
2023-09-22 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is specifically an amendment ('정정신고') to a previous filing. It details the adjustment of stock option quantities and exercise prices due to capital changes (bonus issue). Since this document relates to the issuance of stock options (a form of capital/equity incentive) and does not fit into specific categories like 'Director's Dealing' or 'Share Issue', it is classified as a general regulatory filing.
2023-09-22 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is a '정정신고' (Correction Report) regarding previously disclosed stock option grants. This type of filing relates to changes in capital structure and equity-based compensation, which falls under the category of 'Regulatory Filings' (RNS) as it is a specific corporate disclosure to the financial authorities that does not fit into more specialized categories like M&A or Dividend announcements.
2023-09-22 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically a '정정신고' (Amendment Report). It details changes to stock option quantities and exercise prices for directors due to capital adjustments. Since this document pertains to the issuance and adjustment of stock options (a form of capital/equity incentive), it falls under the category of share-related capital changes. Among the provided options, 'SHA' (Share Issue/Capital Change) is the most appropriate classification for filings related to stock option grants and adjustments.
2023-09-22 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.